Fondaparinux Sodium NDC 67457-583

Product information

Brand name (proprietary)

Fondaparinux Sodium

Generic name (nonproprietary)

fondaparinux sodium

Active ingredients

Fondaparinux sodium — 5 mg/.4mL

Dosage form

Injection, Solution

Route

Subcutaneous

Labeler

Mylan Institutional LLC

Product type

Prescription drug

Marketing category

NDA authorized genericApplication NDA 021345

Marketing start

Jan 5, 2015

Listing expires

Dec 31, 2027

Other FDA classes

Factor Xa Inhibitors (Mechanism)

Identifiers

Product ID 67457-583_9448af58-144f-4611-a462-e8cb12cc7362SPL ID 9448af58-144f-4611-a462-e8cb12cc7362SPL set ID 4b65f642-87f7-4da5-a9c9-02cd1f8d9d16RxCUI 861356, 861360, 861363, 861365UNII X0Q6N9USOZ

Pharmacologic class

Factor Xa Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N467457058304 followed by a unit qualifier and the quantity Copy

Package 67457-0583-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under NDA 021345

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.